HEALTHPEAK PROPERTIES INC (DOC)
US42250P1030 - REIT
We assign a fundamental rating of 3 out of 10 to DOC. DOC was compared to 129 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DOC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
In the past year DOC had a positive cash flow from operations.
Each year in the past 5 years DOC has been profitable.
Each year in the past 5 years DOC had a positive operating cash flow.
1.2 Ratios
DOC's Return On Assets of 1.55% is fine compared to the rest of the industry. DOC outperforms 61.42% of its industry peers.
With a decent Return On Equity value of 3.61%, DOC is doing good in the industry, outperforming 62.99% of the companies in the same industry.
The Return On Invested Capital of DOC (2.53%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.08%.
The last Return On Invested Capital (2.53%) for DOC is above the 3 year average (2.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 3.61% | ||
| ROIC | 2.53% |
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
1.3 Margins
The Profit Margin of DOC (12.08%) is better than 62.99% of its industry peers.
In the last couple of years the Profit Margin of DOC has declined.
DOC has a Operating Margin (22.99%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DOC has declined.
DOC's Gross Margin of 64.69% is on the low side compared to the rest of the industry. DOC is outperformed by 63.78% of its industry peers.
In the last couple of years the Gross Margin of DOC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.99% | ||
| PM (TTM) | 12.08% | ||
| GM | 64.69% |
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
DOC has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DOC has been increased compared to 5 years ago.
DOC has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.58, we must say that DOC is in the distress zone and has some risk of bankruptcy.
DOC's Altman-Z score of 0.58 is in line compared to the rest of the industry. DOC outperforms 48.03% of its industry peers.
The Debt to FCF ratio of DOC is 18.44, which is on the high side as it means it would take DOC, 18.44 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 18.44, DOC is in the better half of the industry, outperforming 74.80% of the companies in the same industry.
DOC has a Debt/Equity ratio of 1.00. This is a neutral value indicating DOC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.00, DOC is in line with its industry, outperforming 59.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 18.44 | ||
| Altman-Z | 0.58 |
ROIC/WACC0.36
WACC6.93%
2.3 Liquidity
A Current Ratio of 0.15 indicates that DOC may have some problems paying its short term obligations.
The Current ratio of DOC (0.15) is worse than 99.21% of its industry peers.
DOC has a Quick Ratio of 0.15. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC has a worse Quick ratio (0.15) than 99.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.15 | ||
| Quick Ratio | 0.15 |
3. Growth
3.1 Past
DOC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.82%.
The Earnings Per Share has been growing by 14.07% on average over the past years. This is quite good.
Looking at the last year, DOC shows a quite strong growth in Revenue. The Revenue has grown by 18.79% in the last year.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.86% yearly.
EPS 1Y (TTM)6.82%
EPS 3Y19.28%
EPS 5Y14.07%
EPS Q2Q%0%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%25.92%
3.2 Future
The Earnings Per Share is expected to decrease by -9.32% on average over the next years.
The Revenue is expected to decrease by -20.89% on average over the next years. This is quite bad
EPS Next Y-36.87%
EPS Next 2Y-32.26%
EPS Next 3Y-17.47%
EPS Next 5Y-9.32%
Revenue Next Year23.17%
Revenue Next 2Y14.15%
Revenue Next 3Y10.31%
Revenue Next 5Y-20.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 46.19, the valuation of DOC can be described as expensive.
DOC's Price/Earnings is on the same level as the industry average.
DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.65.
A Price/Forward Earnings ratio of 84.48 indicates a quite expensive valuation of DOC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
DOC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.56.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.19 | ||
| Fwd PE | 84.48 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DOC is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, DOC is valued a bit cheaper than the industry average as 63.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.62 | ||
| EV/EBITDA | 15.01 |
4.3 Compensation for Growth
A cheap valuation may be justified as DOC's earnings are expected to decrease with -17.47% in the coming years.
PEG (NY)N/A
PEG (5Y)3.28
EPS Next 2Y-32.26%
EPS Next 3Y-17.47%
5. Dividend
5.1 Amount
DOC has a Yearly Dividend Yield of 5.65%, which is a nice return.
Compared to an average industry Dividend Yield of 6.55, DOC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.23, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.65% |
5.2 History
The dividend of DOC decreases each year by -4.01%.
DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.01%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
242.60% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP242.6%
EPS Next 2Y-32.26%
EPS Next 3Y-17.47%
HEALTHPEAK PROPERTIES INC
NYSE:DOC (11/21/2024, 4:22:04 PM)
After market: 21.71 0 (0%)21.71
+0.28 (+1.31%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.18B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.65% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.19 | ||
| Fwd PE | 84.48 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)3.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 3.61% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 22.99% | ||
| PM (TTM) | 12.08% | ||
| GM | 64.69% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.15 | ||
| Quick Ratio | 0.15 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)6.82%
EPS 3Y19.28%
EPS 5Y
EPS Q2Q%
EPS Next Y-36.87%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.79%
Revenue growth 3Y9.86%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y